Cited by 212Syphilis Diagnosis and TreatmentInfectious Diseases and TuberculosisHIV Research and Treatment

Neurosyphilis in a clinical cohort of HIV-1-infected patients.

Open access
Ghanem, Khalil G, Moore, Richard D, Rompalo, Anne M, Erbelding, Emily J, Zenilman, Jonathan M, Gebo, Kelly A·2008·AIDS

Abstract

OBJECTIVES: To describe the risk factors, clinical presentation, and long-term follow up of patients enrolled in a clinical cohort of HIV-infected patients who were diagnosed and treated for neurosyphilis. METHODS: Comprehensive demographic, clinical, and therapeutic data were collected prospectively on all patients between 1990 and 2006. Patients were diagnosed with neurosyphilis if they had positive syphilis serologies and any of the following: (a) one or more cerebrospinal fluid abnormalities on lumbar puncture [white blood cells >10/microl; protein >50 mg/dl; reactive venereal diseases research laboratory], (b) an otherwise unexplained neurological finding. RESULTS: Of 231 newly diagnosed syphilis cases, 41 neurosyphilis cases met entry criteria (median age 38.6 years, 79.1% male). Risk factors for neurosyphilis included a CD4 cell count of less than 350 cells/ml at the time of syphilis diagnosis (odds ratio: 2.87; 95% confidence interval: 1.18-7.02), a rapid plasma regain titer >1: 128 (2.83; 1.11-7.26), and male sex (2.46; 1.06-5.70). Use of any highly active antiretroviral therapy before syphilis infection reduced the odds of neurosyphilis by 65% (0.35; 0.14-0.91). Sixty-three percent of cases presented with early neurosyphilis and the median time to neurosyphilis diagnosis was 9 months. Symptomatic patients had more cerebrospinal fluid abnormalities on initial lumbar puncture than asymptomatic patients (P = 0.01). Follow-up lumbar puncture within 12 months revealed that only 38% had resolution of all cerebrospinal fluid abnormalities. At 1 year, 38% had persistence of their major symptom despite adequate treatment for neurosyphilis. Twelve of 41 (29%) patients were retreated for syphilis. CONCLUSION: Early neurosyphilis was common in this cohort. Highly active antiretroviral therapy to reverse immunosuppression may help mitigate neurological complications of syphilis.

Integrity signals

Registry

Crossref · 10.1097/qad.0b013e32830184df

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Using ART per current HIV guidelines might improve clinical outcomes among persons coinfected with HIV and syphilis.

    “Using ART per current HIV guidelines might improve clinical outcomes among persons coinfected with HIV and syphilis”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [624]

  • Concerns regarding adequate treatment of syphilis among persons with HIV infection might not apply to those with HIV virologic suppression.

    “concerns regarding adequate treatment of syphilis among persons with HIV infection might not apply to those with HIV virologic suppression (624,625).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [624]

  • Limited data indicate that changes in CSF parameters might occur more slowly among persons with HIV infection, especially those with more advanced immunosuppression.

    “Limited data indicate that changes in CSF parameters might occur more slowly among persons with HIV infection, especially those with more advanced immunosuppression (588,624).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [624]

  • People living with HIV on ART have reduced serological failure rates.

    “People living with HIVon ART have reduced serological failure rates.143”

    From BASHH UK guidelines for the management of syphilis 2024 (2024) · cites this paper as [143]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ghanem, K. G., Moore, R. D., Rompalo, A. M., Erbelding, E. J., Zenilman, J. M., & Gebo, K. A.
Affiliations
Johns Hopkins University (US)
Corresponding author
Ghanem, Khalil G
Venue
AIDS
Published
2008-06-19
Volume
22
Issue
10
Pages
1145-1151
ISSN
0269-9370 (ISSN-L)
OpenAlex
W2069132905
Cited by
212
References
19
Citations by year
2026: 10 · 2025: 11 · 2024: 11 · 2023: 12 · 2022: 11 · 2021: 10 · 2020: 9 · 2019: 8 · 2018: 12 · 2017: 12 · 2016: 9 · 2015: 24 · 2014: 12 · 2013: 8 · 2012: 10
FWCI
9.28
Type
journal article
Language
en
Open access
Locations
  • AIDS (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Johns Hopkins University
  • National Institutes of Health (1r01ag026250-01a2)
  • National Institute on Alcohol Abuse and Alcoholism (R01AA016893)
  • National Institute on Aging (R01 AG026250:)
  • National Institute on Drug Abuse (R01-DA11602, U01DA036935, K23 DA00523, K24-DA-00432, R01DA011602, K24DA000432, K23DA000523)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (K23HD047395)
Topics
  • Health Sciences › Medicine › Physiology › Syphilis Diagnosis and Treatment
  • Health Sciences › Medicine › Surgery › Infectious Diseases and Tuberculosis
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords
neurosyphilis, HIV-1 infection, risk factors, CD4 count, RPR titer, highly active antiretroviral therapy, cerebrospinal fluid abnormalities, long-term follow-up
MeSH terms
Adult, Aged, Anti-Bacterial Agents, Female, Humans, Male, Middle Aged, Neurosyphilis, Risk Factors, Cohort Studies, HIV-1, AIDS-Related Opportunistic Infections, CD4 Lymphocyte Count, Retreatment, Antiretroviral Therapy, Highly Active

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review